Faculty of Medicine and Health Sciences
Kuching, Sarawak, 94300, Malaysia
NCT Number: NCT04462016
It is important to bring the blood glucose levels of those with type 2 diabetes mellitus (T2DM) back to normal levels as this can stop the condition from worsening and prevent other conditions that are related to T2DM from developing. One way to maintain healthy blood glucose level is the use of the glycaemic index (GI), which ranks food according to how the body responds to its carbohydrate content. Low GI foods corresponds to low increase in blood glucose levels. Calamansi is a citrus that is believed not to induce an increase in blood glucose levels. Since beverages from calamansi are available and diabetes is a health concern in the community, it is important to investigate the effect of consuming this drink. Finger prick blood were tested in order to obtain the blood glucose levels for calculating the GI for the calamansi drink.
Looking for future studies?
Notify Me18 year–21 year
Male
Interventional
Not applicable
Kuching, Sarawak, 94300, Malaysia
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
250 ml of a commercially sourced calamansi drink
75 g of glucose dissolved in 250 ml of drinking water
Time frame: 30, 60, 90, 120 min after drinking
Capillary blood glucose using glucometer
Time frame: 30, 60, 90, 120 min after drinking
Dipstick test
University Malaysia Sarawak
Other
Blood Glucose Response to a Calamansi Drink in Healthy Adults
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05291806
Blood Glucose Response
Lund, Sweden
View Trial DetailsNCT04197726
Blood Glucose Response
Norwich, Norfolk, United Kingdom
View Trial DetailsNCT02075333
Behavior, Blood Glucose Response
Leeds, United Kingdom
View Trial Details